🔗 Share this article

Treasury head Rachel Reeves has revealed she is planning "targeted steps to address cost of living challenges" in the forthcoming Budget.

During an interview with the BBC, she stated that curbing price rises is a shared responsibility of both the administration and the central bank.

The United Kingdom's inflation rate is projected to be the most elevated among the G7 industrialized countries this calendar year and next.

Potential Energy Cost Measures

Sources suggest the government could intervene to bring down energy bills, for instance by reducing the current 5% level of VAT charged on energy supplies.

A further possibility is to reduce some of the government charges currently added to bills.

Budgetary Constraints and Analyst Predictions

The government will obtain the latest assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will show how much space there is for these actions.

The consensus from the majority of analysts is that Reeves will have to announce tax rises or spending cuts in order to adhere to her self-imposed borrowing rules.

Earlier on Thursday, calculations indicated there was a £22bn deficit for the Treasury chief to resolve, which is at the more modest range of forecasts.

"It is a collective responsibility between the Bank of England and the administration to bear down further on some of the sources of inflation," the Chancellor informed the BBC in Washington, at the yearly gatherings of the IMF and global financial institution.

Tax Commitments and Global Concerns

While a great deal of the focus has been on probable tax rises, the chancellor said the most recent figures from the OBR had not altered her pledge to election pledges not to raise tax levels on earnings tax, sales tax or National Insurance.

She attributed an "uncertain global environment" with rising international and trade concerns for the fiscal revenue measures, likely to be targeted on those "with the broadest shoulders."

International Economic Tensions

Addressing concerns about the UK's economic relations with the Asian nation she said: "The UK's security interests always come first."

Recent declaration by China to tighten trade restrictions on rare earths and other materials that are essential for high-technology production led American leader the US President to suggest an additional 100% import tax on goods from the Asian country, raising the possibility of an full-scale commercial conflict between the two economic giants.

The US Treasury Secretary called China's move "commercial pressure" and "a international production control attempt."

Inquired about accepting the American proposal to join its conflict with China, the Chancellor said she was "deeply worried" by Chinese measures and urged the Chinese government "to avoid restrictions and restrict access."

She said the decision was "harmful for the world economy and generates further headwinds."

"In my view there are areas where we need to challenge China, but there are also important chances to export to China's economy, including financial services and other areas of the economy. We've got to achieve that balance right."

The chancellor also stated she was collaborating with international partners "on our own critical minerals plan, so that we are less reliant."

Health Service Medicine Costs and Investment

Reeves also acknowledged that the cost the National Health Service spends on medicines could rise as a result of ongoing negotiations with the Trump administration and its drugs companies, in return for lower tariffs and investment.

Some of the world's largest drug companies have said in recent statements that they are either pausing or abandoning projects in the United Kingdom, with several attributing the modest returns they are obtaining.

Recently, the Science Minister said the cost the health service pays for medicines would must go up to prevent companies and pharmaceutical investment leaving the UK.

The Chancellor told media: "We have seen because of the pricing regime, that clinical trials, innovative medicines have not been provided in the United Kingdom in the manner that they are in other EU nations."

"We want to ensure that patients receiving treatment from the National Health Service are can access the best life-saving drugs in the globe. And so we are reviewing all of that, and... aiming to obtain additional capital into the UK."